Relative Risk vs. Return Landscape
If you would invest 398.00
in BioTime Inc on April 22, 2013
and sell it today you would earn a total of 21.00
from holding BioTime Inc or generate 5.28%
return on investment over 30
days. BioTime Inc is generating 0.83% of daily returns assuming volatility of 4.64%
on return distribution over 30 days investment horizon. In other words, 61% of equities are less volatile than the company and above 52% of equities are expected to generate higher returns over the next 30 days.
Daily Expected Return (%)
Considering 30-days investment horizon, BioTime Inc is expected to generate 8.59 times more return on investment than the market. However, the company is 8.59 times more volatile than its market benchmark. It trades about 0.18 of its potential returns per unit of risk. The S&P 500 is currently generating roughly 0.56 per unit of risk.
BioTime Operating Margin
Based on recorded statements BioTime Inc has Operating Margin of -708.3%. This is 2547.85% higher than that of Healthcare sector, and 627.88% higher than that of Biotechnology
industry, The Operating Margin for all stocks is 20195.13% higher than the company.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.
BioTime Return On Equity vs Return On Asset
BioTime Inc is rated below average
in return on equity category among related companies. It is rated below average
in return on asset category among related companies .